Pliant Therapeutics, Inc.

Q2 2021 13F Holders

Symbol
PLRX
CUSIP
729139105
Type
Equity
Class
COM
Num filings
82
Total reported value, excl. options
$894 M
Manager Report Date Value ($000) Shares Option Type